Mehmet Sinan Dal

13PUBLICATIONS
179CO-AUTHORS
Liquid biopsiesRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 26, 2026
Primary Cutaneous Lymphomas and Lymphoproliferative Disorders: Current Insights for Classification and Management.

|Oct 29, 2025
Pulmonary Embolism in Hematologic Malignancies: Predictive Value of the D-Dimer/Albumin Ratio and Proposal of the Hema-PE Score.

Esma Sevil Akkurt, Ozlem Duvenci Birben, Mehmet Hakan Akbulut

|Apr 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias.

Abdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal

|Nov 06, 2024
Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Ünal Ataş, Ozan Salim, Utku Iltar

|Sep 13, 2024
A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients.

Özgür Mehtap, Tayfur Toptas, Mehmet S Dal

|Nov 14, 2023
Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye

Atakan Tekinalp, Ayfer Gedük, Aydan Akdeniz

Pageof 3

Frequent Collaborators

6 joint publications

Fevzi Altuntaş

4 joint publications

Tuğçe Nur Yiğenoğlu

4 joint publications

Turgay Ulaş

4 joint publications

Bahar Uncu Ulu